Home About us Contact
|
Home About us Contact | ||
|
|
||
Higuchi Model (higuchi + model)
Selected AbstractsComparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug deliveryJOURNAL OF BIOMEDICAL MATERIALS RESEARCH, Issue 1 2008Dharmendra Jain Abstract The aim of the present study was to develop single dose delivery systems based on nanotechnology for prolonged antibiotic release in a controlled manner. Five different drug,carrier ratios of ciprofloxacin hydrochloride-loaded nanoparticles of albumin, gelatin, chitosan (CS), and lipid [solid lipid nanoparticles (SLNs)] were prepared and characterized. Average particle size was found to be in the range of 73 ± 2 to 98 ± 44 nm for SLNs, 140 ± 7 to 175 ± 24 nm for albumin nanoparticles, 143 ± 18 to 184 ± 27 nm for gelatin nanoparticles, and 247 ± 48 to 322 ± 52 nm for CS nanoparticles. A drug-to-carrier ratio of 0.5:1 was preferred for CS nanoparticles having zeta potential of >20 mV and drug encapsulation of 35.01% ± 2.66%. Similarly, 0.6:1 ratio was preferred for albumin nanoparticles with zeta potential >16 mV and drug encapsulation 48.20% ± 3.01%. Zeta potentials of gelatin nanoparticles loaded with ciprofloxacin suggested that they were unstable and prone to flocculation. SLN with 0.25:1 drug carrier ratio showed 38.71% ± 2.38% drug entrapment and ,28 ± 1 mV surface charge. All the nanoparticles showed sustained drug release avoiding "burst effect" of the free drugs for up to 120 h for albumin nanoparticles, 96 h for CS and gelatin nanoparticles, and 80 h for SLNs. The drug release profiles followed Higuchi model. Results suggest that CS nanoparticles and SLNs can act as promising carriers for sustained ciprofloxacin release in infective conditions. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008 [source] Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug deliveryBIOPHARMACEUTICS AND DRUG DISPOSITION, Issue 7 2010S. K. Umadevi Abstract The objective of this investigation was to develop novel colon specific drug delivery. Aceclofenac, a NSAID, was successfully encapsulated into chitosan microspheres. Various formulations were prepared by varying the ratio of chitosan, span-85 and stirring speed and the amount of glutaraldehyde. The SEM study showed that microspheres have smooth surfaces. Microspheres were characterised by Fourier transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC) to confirm the absence of chemical interactions between drug and polymer and to know the formation of microspheres structure. The microspheres were evaluated for particle size, encapsulation efficiency, drug loading capacity, mucoadhesion studies, stability studies, in vitro and in vivo drug release studies. Particle sizes, as measured by the laser light scattering technique, were of an average size in the range 41,80,µm. The swelling index was in the range 0.37,0.82 and the entrapment efficiency range was 51,75% for all the formulations. The optimised batch ACM13 released 83.6% at 8,h and 104% at 24,h in SCF containing rat caecal content. Eudragit coated chitosan microspheres prevented the release of the aceclofenac in the physiological environment of the stomach and small intestine and released 95.9±0.34% in the colon. With regard to release kinetics, the data were best fitted with the Higuchi model and showed zero order release with non-Fickian diffusion mechanism. The in vivo findings suggest that aceclofenac microspheres exhibit a prolonged effect of aceclofenac in rats and produce a significant anti-inflammatory effect. The findings of the present study conclusively state that chitosan microspheres are promising for colon targeting of aceclofenac to synchronise with chronobiological symptoms of rheumatoid arthritis. Copyright © 2010 John Wiley & Sons, Ltd. [source] Development of hydrogel patch for controlled release of alpha-hydroxy acid contained in tamarind fruit pulp extractINTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 2 2005J. Viyoch Synopsis The aim of this study was to develop hydrogel patch using crosslinked chitosan,starch as polymeric matrix for controlling the release of the natural alpha-hydroxy acid (AHA) contained in the extract of tamarind's fruit pulp. The chitosan (MW 100 000) was blended with corn, tapioca or rice starch in various ratios and then crosslinked with glutaraldehyde. The physical characteristics, mechanical resistance, bio-adhesion property and surface morphology of the prepared hydrogel patches with and without the extract were investigated. The release patterns of the hydrogel patches containing the extract were investigated by measuring the amount of tartaric acid, a major AHA present in the tamarind's fruit pulp extract, accumulated in the receptor medium of the vertical diffusion cell at various time intervals over a period of 6 h. The results indicated that the formulations of chitosan : corn starch 4.5 : 0.5 with glutaraldehyde 0.02% w/w (C4.5C0.5G0.02) or 0.04% w/w (C4.5C0.5G0.04), chitosan : tapioca starch 4.5 : 0.5 with glutaraldehyde 0.04% w/w (C4.5T0.5G0.04) or 0.05% w/w (C4.5T0.5G0.05), and chitosan : rice starch 4.5 : 0.5 with glutaraldehyde 0.04% w/w (C4.5R0.5G0.04) and chitosan : rice starch 4.0 : 1.0 with glutaraldehyde 0.03% w/w (C4.0R1.0G0.03) provided the flexible and elastic patches with good bio-adhesive property. The tensile strength values ranged from 5 to15 N mm,2 and the elasticity ranged from 30 to 60%. The addition of the extract in these formulations significantly increased the tensile strength values of the obtained patches. The patch of C4.0R1.0G0.03 formulation containing the extract showed relatively highest porosity, corresponding to its highest amount (12.02 ± 0.33 mg) and rate (0.452 ± 0.012 mg mm,2 min,1/2) of tartaric acid released. The amounts of tartaric acid released from the developed hydrogel patches were proportional to a square root of time (Higuchi's model), particularly the release from C4.0R1.0G0.03 (R2, 0.9978 ± 0.0020) and C4.5R0.5G0.04 (R2, 0.9961 ± 0.0024) patches. Résumé Le but de cette étude était de développer un patch hydrogel en utilisant, en tant que matrice polymère, un mélange chitosane/amidon réticulé pour le contrôle du relargage d', -hydroxyacide naturel contenu dans l'extrait de la pulpe du fruit du tamarinier. Du chitosane (MW 100 000) a été mélangéà des farines de maïs, de tapioca ou de riz dans différentes proportions, les mélanges ont été réticulés avec du glutaraldéhyde. Les caractéristiques physiques, résistance mécanique, propriétés de bio adhésion et morphologie de surface des patchs hydrogels préparés avec et sans extrait ont étéétudiées. Le profil de relargage des patchs hydrogels contenant l'extrait a étéétudié en mesurant la quantité d'acide tartarique, , -aminoacide majoritaire présent dans l'extrait, accumulé dans le milieu récepteur d'une cellule à diffusion verticale en fonction du temps sur une période de 6 heures. Les résultats ont montré que les formulations contenant: ,,un mélange chitosane/amidon de maïs dans un rapport 4.5 : 0.5 réticulé avec 0.02% ou 0.04% poids/poids de glutaraldéhyde (respectivement C4.5C0.5G0.02 et C4.5 C0.5 G0.04) ou ,,un mélange de chitosane/amidon de tapioca dans un rapport 4.5 : 0.5 réticulé avec 0.04% ou 0.05% poids/poids de glutaraldéhyde (C4.5T0.5 G0.04ou C4.5 T0.5 G0.05) ,,ainsi que le mélange chitosane/amidon de riz dans un rapport 4.5 : 0.5 réticulé avec 0.04% poids/poids de glutaraldehyde (C4.5R0.5 G0.04) ,,et le mélange chitosane/amidon de riz dans un rapport 4.0 : 1.0 réticulé avec 0,03% poids/poids de glutaraldehyde (C4.0 R1.0 G0.03) conduisaient à des patchs flexibles et élastiques avec de bonnes propriétés bio adhésives. Leur résistance mécanique varie de 5 à 15 N/m2 et leur élasticité de 30 à 60%. L'addition de l'extrait de fruit à ces formules augmente significativement la résistance mécanique des patchs. Le patch C4.0R1.0 G0.03 contenant l'extrait montre la plus grande porosité correspondant à la quantité d'acide tartarique relargué la plus élevée (12.02 ± 0.33 mg), ainsi qu'à la plus grande vitesse de relargage (0.452 ± 0.012 mg mm- 2 mn- 1/2). Les quantités d'acide tartarique relarguées à partir de patchs hydrogels développés sont proportionnelles à la racine carrée du temps (modèle d'Higuchi), en particulier pour les patchs C4.0 R1.0G0.03 (R2, 0.9978 ± 0.0020) et C4.5R0.5 C0.004 (R2, 0.9061 ± 0.0024). [source] In vitro percutaneous penetration of acyclovir from solvent systems and Carbopol 971-P hydrogels: Influence of propylene glycolJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 5 2005O. Díez-Sales Abstract The mechanism underlying propylene glycol (PG) effects on acyclovir (ACV) penetration through human epidermis were studied. Solvent systems and Carbopol gels containing increasing percentage of PG (from 0% to 70%, w/w) were used. Viscosity studies of both vehicles were carried out to characterise the influence of rheological behaviour. In solvent systems skin permeation values of ACV increase as the concentration of PG increase yielding a maximum enhancement ratio (ER,=,10) for 70% PG. The release rate of ACV from gels was determined. Higuchi's model was used to estimate the apparent diffusion coefficient of the drug. These values show a decrease as the content of PG in the vehicle increases; this effect could be attributed to the increase of the viscosity in the diffusional pathway. When gels are used skin permeation values of ACV were smaller than those of the solvent systems. This could be attributed to the network structure created by the polymer that increases the length of the diffusional pathway. The maximum ER (=6.8) was for Carbopol gel containing 50% PG. Therefore, these gels can be considered candidates for further research to confirm their usefulness as delivery systems for ACV topical formulations. © 2005 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 94:1039,1047, 2005 [source] | ||||||||||